Companies

Marijuana Dispensary Stocks Will Soon Be Thanking Secretive VR Firm

Marijuana Dispensary Stocks Will Soon be Thanking Secretive VR Firm

Marijuana Dispensary Stocks Will Soon be Thanking Secretive VR Firm

If these headsets make ordering marijuana easier, which would in turn increase sales, this technology will be another boon for marijuana dispensary stocks.

Aurora Cannabis Inc. Is Making a Push into Hemp: Is it a Good Idea?

Aurora Cannabis Inc. Is Making a Push into Hemp: Is it a Good Idea?

Aurora Cannabis Inc. today is one of the pre-eminent marijuana producers listed on the TSX Venture Exchange with a market capitalization just shy of $750 million, making it the fourth-largest marijuana stock behind only GW Pharmaceuticals PLC- ADR, Canopy Growth Corp., and Aphria Inc.

Better Know a Marijuana Stock: Arena Pharmaceuticals

Better Know a Marijuana Stock: Arena Pharmaceuticals

Unlike GW Pharmaceuticals and Zynerba Pharmaceuticals, which rely on cannabinoid-based medicines to fill out the entirety of their drug-development pipelines, Arena Pharmaceuticals is one of the drug developers that have some of their pipelines devoted to cannabinoid-type therapeutics or CB agonists and other portions devoted to non-cannabinoid medicines.

If Warren Buffett Were to Buy 1 Marijuana Stock, it Would Be Aphria Inc.

If Warren Buffett Were to Buy 1 Marijuana Stock, it Would Be Aphria Inc.

Warren Buffett is well known as the most successful investor of all time. Buffett spent his formative years under the tutelage of Benjamin Graham, who is known today as the “father of value investing.” Let’s see whether or not Aphria Inc. can pass Buffett’s mentor’s criteriea test.

Here’s Why Emerging Marijuana Stock Cara Therapeutics Inc. Surged

Here’s Why Emerging Marijuana Stock Cara Therapeutics Inc. Surged

Shares of Cara Therapeutics Inc., a clinical-stage biotech company with a focus on treating pain and pruritus, rocketed higher by as much as 11% during Wednesday’s trading session after providing an update to its phase 3 trial involving kappa opioid receptor agonist CR845.

The Very First Cannabis Stock ETF Is Now in Bear-Market Territory

The Very First Cannabis Stock ETF is Now in Bear-Market Territory

The first cannabis stock ETF of its kind, the Horizons Marijuana Life Sciences Index ETF allows investors to own more than a dozen pot stocks through a single investment fund. Today, however, is a different story.

Say Hello to the Largest North American Marijuana Stock IPO

Say Hello to the Largest North American Marijuana Stock IPO

In April, investors were privy to the very first marijuana stock ETF, which debuted on the Toronto Stock Exchange with slightly more than a dozen holdings. This represented the very first time a basket fund was created for investors to easily diversify their pot-stock holdings. And last week, investors witnessed another marijuana first: the largest North American marijuana stock IPO of all-time.

Canadian Cannabis Investors Bogart Deals in America

Canadian Cannabis Investors Bogart Deals in America

There is so much Canadian cannabis investment money right now that it is cascading down into the United States and Canadian investors are easily outbidding domestic acquirers.

Green bubble? Cannabis investors on white-knuckle ride as share prices fall

Green Bubble? Cannabis Investors on White-Knuckle Ride as Share Prices Fall

Canadian marijuana stocks have been on a punishing slide for three straight months despite a temporary blip of investor fever in April that sent share prices soaring to record highs as Ottawa tabled legislation to legalize pot.

Which Cannabis Stock Could Be First to $1 Billion in Annual Sales?

Which Cannabis Stock Could Be First to $1 Billion in Annual Sales?

If there is a “Holy Grail” milestone out there for cannabis stocks, it’s the $1 billion sales mark. The first cannabis company to hit $1 billion in sales will likely validate the industry to Wall Street and investors. But which marijuana stock has the best chance at being first to $1 billion in annual sales?

High Times Acquisition: Company Valued at $70 Million

High Times Acquisition: Company Valued at $70 Million

On June 1, 2017, High Times announced that controlling interest in the company had been acquired by 20 investors, a group comprised of cannabis industry members, entrepreneurs and entertainment veterans. Oreva Capital, a Los Angeles-based investment firm, led the High Times acquisition, valuing the company at $70 million. The company will now operate as High Times Holding Company.

Billion Dollar Fund Manager Targets Cannabis

Billion Dollar Fund Manager Targets Cannabis

First Trust Portfolios filed an S-6 on May 3oth with the Securities and Exchange Commission for a Medical Cannabis Portfolio Series – FT 6766 that is seeking above average capital appreciation.

Canopy Growth Corp.: Are There Any Puffs Left to Smoke?

Canopy Growth Corp.: Are There Any Puffs Left to Smoke?

There are many reasons why Canopyis falling faster than its peers, but a big reason is the fact that Canopy was one of the first firms to the party. Canopy was one of the only ways to invest in the emerging marijuana industry, but now it is just one of many options to get in on the marijuana party.

Marijuana Breathalyzer Company Raises $8.1M in Series B Financing

Marijuana Breathalyzer Company Raises $8.1M in Series B Financing

On May 23, 2017, Hound Labs Inc., a marijuana breathalyzer company in Oakland, announced that it has closed its Series B round of financing with $8.1 million from Benchmark, a California-based venture capital firm that has made successful early-stage investments in companies like Uber and Snapchat, among others.

Two Marijuana Stocks Suspended Temporarily by SEC

Two Marijuana Stocks Suspended Temporarily by SEC

On May 19, 2017, the U.S. Securities and Exchange Commission announced the temporary suspension of two marijuana stocks that trade on the OTC Markets, with both orders of suspension related to the companies neglecting to provide accurate and up-to-date information.

This New Study Should Encourage Marijuana Stock Investors

This New Study Should Encourage Marijuana Stock Investors

The marijuana industry, and marijuana stock investors for that matter, have been expanding by leaps and bounds over the past two decades. One good way to keep this up is through university-based clinical studies. Studies like these really fan the flame of what might be possible with cannabis-based medicines.

Canadian Cannabis Stock Rises With Friday's Cultivation Announcement

Canadian Cannabis Stock Rises With Friday’s Cultivation Announcement

On May 19, 2017, Beleave Inc. (CNX:BE) announced that its subsidiary, First Access Medical Inc., had been awarded a cultivation license from Health Canada, prompting the Canadian cannabis stock to rise 7.62% on Friday.

Better Know a Marijuana Stock: Canopy Growth Corp.

Better Know a Marijuana Stock: Canopy Growth Corp.

A major Canadian medical marijuana player, Canopy Growth is a producer and retailer of medical cannabis products and oils in our neighbor to the north. It’s also the only other marijuana stock other than GW Pharmaceuticals to bear a $1 billion valuation.

Investors Are Betting Big Against Marijuana Stock Insys Therapeutics

Investors Are Betting Big Against Marijuana Stock Insys Therapeutics

As of April 13, 2017, more than 10.4 million shares of Insys Therapeutics (NASDAQ: INSY) were sold short. That’s 44% of the marijuana stock’s float. Investors have clearly bet big against Insys, anticipating that the stock will sink.


Page 1 of 612345...Last »
Top